Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metal ion catalysis refers to the process by which metal ions, such as copper (Cu²⁺) and iron (Fe³⁺), facilitate and accelerate chemical reactions—especially in biological systems. These metal ions are often found as cofactors in metalloenzymes, where they play critical roles in catalyzing a wide range of biochemical transformations. Cu²⁺ and Fe³⁺ assist enzymes by stabilizing negative charges, polarizing bonds, acting as Lewis acids, and facilitating electron transfer. Applications include biological systems, environmental chemistry (Fenton-like reactions), and industrial catalysts. The combination of copper and iron ions often results in synergistic effects, improving catalytic performance. Redox changes underpin their ability to mediate electron transfer steps crucial for catalysis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metal Ion Catalysis (Cu²⁺, Fe³⁺).